Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease

Movement Disorders : Official Journal of the Movement Disorder Society
V KaasinenJ O Rinne

Abstract

Novelty seeking is a temperament trait characterized by impulsiveness and exploratory behavior. Dopamine has been suggested to be the primary neurotransmitter modulator of novelty seeking, and in young healthy subjects, a correlation between increased novelty seeking and decreased insular cortical dopamine D2 receptor availability has been reported. The proposed link between dopamine deficiency and reduction in novelty seeking in Parkinson's disease is controversial. The present study examined whether a link between insular D2 receptor availability and novelty seeking can be replicated in Parkinson's disease patients. [11C]FLB 457 positron emission tomography imaging was carried out in 28 patients with Parkinson's disease, and the data were analyzed using voxel-based statistical analysis. The results demonstrated a negative correlation between the novelty seeking score and the dopamine D2 availability bilaterally in the insular cortex (corrected P=0.001; r=-0.74 [right hemisphere]; r=-0.66 [left hemisphere]). The results provide further support for a relationship between novelty seeking and insular D2 receptors. They indicate that the association is cross-cultural, independent of age, and unaffected by dopaminergic degeneration.

References

Dec 1, 1993·Archives of General Psychiatry·C R CloningerT R Przybeck
Mar 1, 1993·Neurology·M A MenzaN E Forman
Feb 13, 1997·Nature·L FardeE Jönsson
Oct 10, 1998·The American Journal of Psychiatry·A BreierD Pickar
Feb 5, 2000·The International Journal of Eating Disorders·C M GordonA J Fischman
Feb 15, 2000·The American Journal of Psychiatry·A LaaksoJ Hietala
Aug 30, 2000·Nuclear Medicine and Biology·R N GunnP M Grasby
Feb 7, 2001·The American Journal of Psychiatry·V KaasinenJ O Rinne
May 2, 2001·Nature Reviews. Neuroscience·A J CalderA W Young
Oct 19, 2001·Nuclear Medicine Communications·Y SudoL Farde
Nov 1, 2001·Proceedings of the National Academy of Sciences of the United States of America·V KaasinenJ O Rinne
Oct 16, 2002·Neuroscience Letters·Valtteri KaasinenJuha O Rinne
Apr 1, 2003·Annals of Neurology·Pierre Krolak-SalmonFrançois Mauguière
Sep 2, 2003·NeuroImage·Simon A SurguladzeMary L Phillips

❮ Previous
Next ❯

Citations

Nov 16, 2011·Journal of Neurology·Michele Poletti, Ubaldo Bonuccelli
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Albert GjeddeArne Møller
Feb 13, 2008·Fiziologiia cheloveka·M A KulikovaA G Tonevitskiĭ
Feb 18, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·A H EvansA J Lees
Apr 17, 2014·Brain : a Journal of Neurology·Leigh ChristopherAntonio P Strafella
Jul 16, 2014·Brain Structure & Function·Hikaru TakeuchiRyuta Kawashima
Jul 4, 2015·Journal of Neurology·Charlotte A HaaxmaBastiaan R Bloem
Apr 9, 2015·Frontiers in Systems Neuroscience·Alberto Costa, Carlo Caltagirone
Sep 10, 2014·PloS One·Elise G ValdésKarin Wirdefeldt
Jun 24, 2016·Journal of Neurology·Toru IshiiHidenao Fukuyama
Mar 6, 2007·Biological Psychiatry·Akihiro TakanoTetsuya Suhara
Jan 15, 2017·Journal of the Neurological Sciences·Gabriella SantangeloCarmine Vitale
Oct 5, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Andrew J LawrenceBarbara J Sahakian
Dec 24, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Emma S NymanLeena Peltonen
Jan 31, 2009·Depression and Anxiety·Franklin R SchneierMarc Laruelle
Jan 18, 2006·Brain : a Journal of Neurology·Atsunobu SuzukiMitsuru Kawamura
Jun 24, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Eugénie LhomméePaul Krack
Sep 18, 2010·British Journal of Pharmacology·Paul CummingJeffrey W Dalley
Mar 27, 2020·Frontiers in Psychiatry·Peiyu HuangMinming Zhang
Jul 5, 2018·Brain Imaging and Behavior·Avner ThalerUNKNOWN LRRK2 Ashkenazi Jewish consortium
Mar 4, 2021·NPJ Parkinson's Disease·Giorgia PonsiSalvatore Maria Aglioti
Nov 3, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Gil Leurquin-SterkKoen Van Laere

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.